Evaluating the Safety of Cell Therapy: What You Need to Know
Scrubs
JANUARY 10, 2024
Thorough understanding and mitigation of immunogenicity risks are integral to ensuring patient safety. Tumorigenicity: The possibility of administered cells developing into tumors is a pivotal aspect scrutinized during safety evaluations.
Let's personalize your content